Modeling cancer-associated mutations of PTEN in mice

Abstract

Manipulation of mammalian genome and generation of genetically engineered mouse models (GEMMs) has revolutionized the scientific approach to address biological questions. To date, a number of genetargeting strategies have been devised and are available to investigators for the generation of genetically modified mouse lines. Nevertheless, irrespective of the methodological approach selected, there remain critical molecular steps that need to be performed and put in place in order to obtain controlled and wellcharacterized new animal models. Here we provide technical details for the (1) handling and maintenance of mouse embryonic stem (ES) cells; (2) analysis of genomic DNA by Southern Blot; and (3) sequencing and PCR analysis of recombined genomic DNA. These experimental steps have been undertaken for the generation of new mouse models harboring cancer-associated PTEN mutations.